Evidence map›Paper›PMID 29922145›Full record

ArticleFrontiers in aging neuroscience2018

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier.

Antti Tolonen, Hanneke F M Rhodius-Meester, Marie Bruun, Juha Koikkalainen, Frederik Barkhof, Afina W Lemstra, Teddy Koene, Philip Scheltens, Charlotte E Teunissen, Tong Tong and 12 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Alcohol Use Disorder and Dementia: A Review.Alcohol research : current reviews · 2024
    Review
  11. cCOG Web-Based Cognitive Assessment Tool.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Optimizing cCOG, a Web-based tool, to detect dementia with Lewy Bodies.Alzheimer's & dementia (Amsterdam, Netherlands) · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Evaluating 2-[NeuroImage. Clinical · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Antti TolonenVTT Technical Research Centre of Finland, Tampere, Finland.
Hanneke F M Rhodius-MeesterAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Marie BruunDanish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark.
Juha KoikkalainenCombinostics Ltd., Tampere, Finland.
Frederik BarkhofAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Afina W LemstraAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Teddy KoeneAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Philip ScheltensAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Charlotte E TeunissenAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Tong TongImperial College London, London, United Kingdom.
Ricardo GuerreroImperial College London, London, United Kingdom.
Andreas SchuhImperial College London, London, United Kingdom.
Christian LedigImperial College London, London, United Kingdom.
Marta BaroniInstitute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
Daniel RueckertImperial College London, London, United Kingdom.
Hilkka SoininenInstitute of Clinical Medicine and Department of Neurology, University of Eastern Finland, Kuopio, Finland.
Anne M RemesInstitute of Clinical Medicine and Department of Neurology, University of Eastern Finland, Kuopio, Finland.
Gunhild WaldemarDanish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark.
Steen G HasselbalchDanish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark.
Patrizia MecocciInstitute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
Wiesje M van der FlierAlzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands.
Jyrki LötjönenCombinostics Ltd., Tampere, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical decision support systems (CDSSs) hold potential for the differential diagnosis of neurodegenerative diseases. We developed a novel CDSS, the PredictND tool, designed for differential diagnosis of different types of dementia. It combines information obtained from multiple diagnostic tests such as neuropsychological tests, MRI and cerebrospinal fluid samples. Here we evaluated how the classifier used in it performs in differentiating between controls with subjective cognitive decline, dementia due to Alzheimer's disease, vascular dementia, frontotemporal lobar degeneration and dementia with Lewy bodies. We used the multiclass Disease State Index classifier, which is the classifier used by the PredictND tool, to differentiate between controls and patients with the four different types of dementia. The multiclass Disease State Index classifier is an extension of a previously developed two-class Disease State Index classifier. As the two-class Disease State Index classifier, the multiclass Disease State Index classifier also offers a visualization of its decision making process, which makes it especially suitable for medical decision support where interpretability of the results is highly important. A subset of the Amsterdam Dementia cohort, consisting of 504 patients (age 65 ± 8 years, 44% females) with data from neuropsychological tests, cerebrospinal fluid samples and both automatic and visual MRI quantifications, was used for the evaluation. The Disease State Index classifier was highly accurate in separating the five classes from each other (balanced accuracy 82.3%). Accuracy was highest for vascular dementia and lowest for dementia with Lewy bodies. For the 50% of patients for which the classifier was most confident on the classification the balanced accuracy was 93.6%. Data-driven CDSSs can be of aid in differential diagnosis in clinical practice. The decision support system tested in this study was highly accurate in separating the different dementias and controls from each other. In addition to the predicted class, it also provides a confidence measure for the classification.

Indexed as

Alzheimer’s diseaseclassificationdecision supportdementia with Lewy bodiesfrontotemporal lobar degenerationneurodegenerative diseasesvascular dementia

Identifiers

PMID29922145
PMCPMC5996907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.